Cargando…

Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients

INTRODUCTION: This study aimed to investigate the clinical characteristics, risk factors, and outcomes of infection-related hospitalization (IRH) in patients with lupus nephritis (LN) and ANCA glomerulonephritis after intensive immunosuppressive therapy. METHODS: Patients diagnosed with LN or ANCA g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Peihong, Li, Jianbo, Wen, Qiong, Qiu, Yagui, Liang, Wenyi, Wang, Junxian, Yu, Jing, Zhong, Zhong, Yang, Xiao, Yu, Xueqing, Ye, Qing, Huang, Fengxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269069/ https://www.ncbi.nlm.nih.gov/pubmed/32406300 http://dx.doi.org/10.1080/0886022X.2020.1763400

Ejemplares similares

Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia
por: Wen, Qiong, et al.
Publicado: (2022)

Concurrent presentation of IgG4-related tubulointerstitial nephritis and ANCA MPO crescentic glomerulonephritis
por: Wu, Henry H.L., et al.
Publicado: (2022)

Interstitial nephritis without glomerulonephritis in ANCA-associated vasculitis: a case series and literature review
por: He, Xuxia, et al.
Publicado: (2022)

A Case of Lupus Nephritis Preceded by Minimal Change Disease and Membranous Glomerulonephritis
por: Zhang, Fengxia, et al.
Publicado: (2023)

ANCA-Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab
por: Sharmeen, Saika, et al.
Publicado: (2018)

What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?
por: Xiao, Xiang, et al.
Publicado: (2022)

Strongyloides Duodenitis in an Immunosuppressed Patient with Lupus Nephritis
por: Jegadeesan, Ramprasad, et al.
Publicado: (2018)

Educational Case: Lupus Nephritis as an Example of Immune Complex–Mediated Glomerulonephritis
por: Jebakumar, Deborah, et al.
Publicado: (2020)

Not Lupus Nephritis but a Rare Case of Drug-Induced Pauci-Immune Glomerulonephritis
por: Hang, Stephanie, et al.
Publicado: (2022)

ANCA vasculitis presenting with acute interstitial nephritis without glomerular involvement
por: Plafkin, Callie, et al.
Publicado: (2019)

Unusual association of a positive pANCA pauci-immune extracapillary glomerulonephritis in a lupus patient
por: Fadili, W., et al.
Publicado: (2012)

Cardiovascular risk assessment in lupus nephritis and ANCA-associated vasculitis in real-world nephrology practice
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis
por: Zickert, Agneta, et al.
Publicado: (2023)

Meta-Analytical Accuracy of ANCA Renal Risk Score for Prediction of Renal Outcome in Patients With ANCA-Associated Glomerulonephritis
por: Xia, Mengdi, et al.
Publicado: (2022)

ANCA negative pauci-immune glomerulonephritis with systemic involvement
por: Sampathkumar, K., et al.
Publicado: (2010)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012)

ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
por: Syed, Rafeel, et al.
Publicado: (2015)

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse
por: Göçeroğlu, Arda, et al.
Publicado: (2016)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

ANCA glomerulonephritis after the Moderna COVID-19 vaccination
por: Sekar, Arjun, et al.
Publicado: (2021)

MPO-ANCA Rapidly Progressive Glomerulonephritis with Immune Deposits
por: Acosta, Eric, et al.
Publicado: (2022)

Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis
por: Zhao, Xiaohong, et al.
Publicado: (2020)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients
por: Zakharova, Elena V., et al.
Publicado: (2016)

pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2022)

Risk Factors for Renal Failure in Patients with Lupus Nephritis: Data from the Spanish Registry of Glomerulonephritis
por: Vozmediano, Carmen, et al.
Publicado: (2012)

Changing trends in presentation and indications of biopsy in lupus nephritis: data from the Spanish Registry of Glomerulonephritis
por: Shabaka, Amir, et al.
Publicado: (2021)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
por: Lin, Wei, et al.
Publicado: (2021)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Insulin autoimmune syndrome in a patient with ANCA-associated glomerulonephritis
por: Ka, Tsuneyoshi, et al.
Publicado: (2008)

Necrotizing ANCA-Positive Glomerulonephritis Secondary to Culture-Negative Endocarditis
por: Van Haare Heijmeijer, Sophie, et al.
Publicado: (2015)

De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19
por: Uppal, Nupur N., et al.
Publicado: (2020)

Long-Term Kidney Prognosis and Pathological Characteristics of Late-Onset Lupus Nephritis
por: Tian, Na, et al.
Publicado: (2022)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era
por: Pattanaik, Debendra, et al.
Publicado: (2022)

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
por: Hunnicutt, Jacob N., et al.
Publicado: (2023)

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
por: Yap, Desmond Y. H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_urv6o8rdbb29dej848ciqlt0rg